+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genetic Testing Markets for Epilepsy, Autism, Alzheimer's and Other Neurologic Conditions

  • ID: 5241523
  • Report
  • January 2021
  • Region: Global
  • 40 Pages
  • Kalorama Information
1 of 3

FEATURED COMPANIES

  • Ambry Genetics
  • Asuragen
  • Blueprint Genetics
  • Cytox Group Limited
  • Genedx
  • Invitae
  • MORE

Genetic involvement in the pathogenesis of the neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases.  Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes for neurological conditions.

The area of inherited condition testing for neurological conditions has become a major area of activity in the last decade or so, coinciding with the acceleration of sequencing and other technologies. Increasing awareness of neurological disorders, the aging population, and continued advancements in medical genetics will likely drive the neurological genetic testing market.

This report Genetic Testing Markets for Epilepsy, Autism, Alzheimer’s and Other Neurologic Conditions focuses on the neurological segments of the inherited/genetic disease testing market, including autism, Alzheimer’s disease and other neurological diseases. Next-generation sequencing has provided new abilities in recent years to affordably produce much larger volumes of sequence. It offers the choice of single genes, panels, exomes and other methods.

As part of its coverage, this report provides:

  • Overview of Market
  • Selected Companies and Products in the Neurological Genetic Testing Market
  • Genetic Neurological Testing 2020-2025 (in $ millions)
  • Genetic Testing by Disease Type (Autism, Alzheimer’s and other Neurological Diseases) 2020-2025 (in $ millions)
  • COVID-19 Impact
  • Companies in the Market
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Ambry Genetics
  • Asuragen
  • Blueprint Genetics
  • Cytox Group Limited
  • Genedx
  • Invitae
  • MORE

CHAPTER 1: EXECUTIVE SUMMARY

OVERVIEW
SCOPE AND METHODOLOGY
MARKET OVERVIEW AND POTENTIAL

  • Table 1-1: Genetic Neurological Testing 2020-2025 (in $ millions)

COVID-19 IMPACT

CHAPTER 2: INTRODUCTION

OVERVIEW
Autism
Alzheimer’s Disease
Other Neurological Diseases
Types of Testing
Limitations in Exome Sequencing
Costs of Exome Sequencing
Areas of Difficulty for NGS to Penetrate Market
Role of FISH/ISH
De Novo Mutations Not Excluded

CHAPTER 3: PRODUCTS AND MARKET POTENTIAL

GENETIC TESTING FOR AUTISM
GENETIC TESTING FOR ALZHEIMER’S DISEASE
GENETIC TESTING FOR OTHER SELECT NEUROLOGICAL DISEASES

  • Table 3-1: Selected Companies and Products in the Neurological Genetic Testing Market

MARKET REVENUE AND FORECAST

  • Table 3-2: Genetic Neurological Testing 2020-2025 (in $ millions)
  • Table 3-3: Genetic Testing by Disease Type Autism, Alzheimer’s and other Neurological Diseases 2020-2025 (in $ millions)

CHAPTER 4: MARKET PARTICIPANTS

AMBRY GENETICS

  • Table 4-1: Ambry Genetics Corporate Summary
  • Company Information

ARUP LABORATORIES

  • Table 4-2: ARUP Laboratories Corporate Details
  • Company Information

ASURAGEN

  • Table 4-3: Asuragen Corporate Summary
  • Company Information

ATHENA DIAGNOSTICS, INC.

  • Table 4-4: Athena Diagnostics Corporate Summary
  • Company Information

BLUEPRINT GENETICS

  • Table 4-5: Blueprint Genetics Corporate Summary
  • Company Information

CENTOGENE AG

  • Table 4-6: Centogene Corporate Summary
  • Company Information

CYTOX GROUP LIMITED

  • Table 4-7: Cytox Corporate Summary
  • Company Information

FULGENT GENETICS

  • Table 4-8: Fulgent Genetics Corporate Summary
  • Company Information

GENEDX

  • Table 4-9: GeneDx Corporate Summary
  • Company Information

ILLUMINA

  • Table 4-10: Illumina Corporate Summary
  • Company Information

INVITAE

  • Table 4-11: Invitae Corporate Summary
  • Company Information

LABORATORY CORPORATION OF AMERICA

  • Table 4-12: LabCorp Corporate Summary
  • Company Information

LINEAGEN

  • Table 4-13: Lineagen Corporate Summary
  • Company Information

PERKINELMER, INC.

  • Table 4-14: PerkinElmer Corporate Summary
  • Company Information

QUEST

  • Table 4-15: Quest Corporate Summary
  • Company Information

THERMO FISHER SCIENTIFIC

  • Table 4-16: Thermo Fisher Scientific Corporate Summary
  • Company Information
Note: Product cover images may vary from those shown
3 of 3
  • Ambry Genetics
  • Arup Laboratories
  • Asuragen
  • Athena Diagnostics
  • Blueprint Genetics
  • Centogene AG
  • Cytox Group Limited
  • Fulgent Genetics
  • Genedx
  • Illumina
  • Invitae
  • Laboratory Corporation of America
  • Lineagen
  • PerkinElmer
  • Quest
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
Adroll
adroll